Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per Westermark
Giampaolo Merlini

Showing results (421-430 of 587) with videos related to

Pageof 59
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 2013
Reply to S. Girnius et alGiovanni Palladini, Angela Dispenzieri, Morie Gertz, et al.
Protein Science : a Publication of the Protein Society|August 10, 2017
Systemic AA amyloidosis in the red fox (Vulpes vulpes)Anna Rising, Ella Cederlund, Carina Palmberg, et al.
American Journal of Hematology|July 27, 2005
Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004Morie A Gertz, Ray Comenzo, Rodney H Falk, et al.
Protein Science : a Publication of the Protein Society|January 24, 2007
Lysine 58-cleaved beta2-microglobulin is not detectable by 2D electrophoresis in ex vivo amyloid fibrils of two patients affected by dialysis-related amyloidosisSofia Giorgetti, Monica Stoppini, Glenys A Tennent, et al.
Blood|September 6, 2013
Primary therapy of Waldenstrom macroglobulinemia (WM) with weekly bortezomib, low-dose dexamethasone, and rituximab (BDR): long-term results of a phase 2 study of the European Myeloma Network (EMN)Meletios A Dimopoulos, Ramón García-Sanz, Maria Gavriatopoulou, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|July 22, 2015
Vascular alterations in apolipoprotein A-I amyloidosis (Leu75Pro). A case-control studyMaria Lorenza Muiesan, Massimo Salvetti, Anna Paini, et al.
Elife|March 3, 2025
A conformational fingerprint for amyloidogenic light chainsCristina Paissoni, Sarita Puri, Luca Broggini, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|February 13, 2023
Impact of cytogenetic abnormalities on treatment outcomes in patients with amyloid light-chain amyloidosis: subanalyses from the ANDROMEDA studyShaji Kumar, Angela Dispenzieri, Divaya Bhutani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 24, 2012
New criteria for response to treatment in immunoglobulin light chain amyloidosis based on free light chain measurement and cardiac biomarkers: impact on survival outcomesGiovanni Palladini, Angela Dispenzieri, Morie A Gertz, et al.
Molecules (Basel, Switzerland)|April 3, 2021
Clinical Amyloid Typing by Proteomics: Performance Evaluation and Data Sharing Between Two CentresDiana Canetti, Francesca Brambilla, Nigel B Rendell, et al.
Pageof 59

Showing results (421-430 of 587) with videos related to

Sort By:
Pageof 59
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 2013
Reply to S. Girnius et alGiovanni Palladini, Angela Dispenzieri, Morie Gertz, et al.
Protein Science : a Publication of the Protein Society|August 10, 2017
Systemic AA amyloidosis in the red fox (Vulpes vulpes)Anna Rising, Ella Cederlund, Carina Palmberg, et al.
American Journal of Hematology|July 27, 2005
Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004Morie A Gertz, Ray Comenzo, Rodney H Falk, et al.
Protein Science : a Publication of the Protein Society|January 24, 2007
Lysine 58-cleaved beta2-microglobulin is not detectable by 2D electrophoresis in ex vivo amyloid fibrils of two patients affected by dialysis-related amyloidosisSofia Giorgetti, Monica Stoppini, Glenys A Tennent, et al.
Blood|September 6, 2013
Primary therapy of Waldenstrom macroglobulinemia (WM) with weekly bortezomib, low-dose dexamethasone, and rituximab (BDR): long-term results of a phase 2 study of the European Myeloma Network (EMN)Meletios A Dimopoulos, Ramón García-Sanz, Maria Gavriatopoulou, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|July 22, 2015
Vascular alterations in apolipoprotein A-I amyloidosis (Leu75Pro). A case-control studyMaria Lorenza Muiesan, Massimo Salvetti, Anna Paini, et al.
Elife|March 3, 2025
A conformational fingerprint for amyloidogenic light chainsCristina Paissoni, Sarita Puri, Luca Broggini, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|February 13, 2023
Impact of cytogenetic abnormalities on treatment outcomes in patients with amyloid light-chain amyloidosis: subanalyses from the ANDROMEDA studyShaji Kumar, Angela Dispenzieri, Divaya Bhutani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 24, 2012
New criteria for response to treatment in immunoglobulin light chain amyloidosis based on free light chain measurement and cardiac biomarkers: impact on survival outcomesGiovanni Palladini, Angela Dispenzieri, Morie A Gertz, et al.
Molecules (Basel, Switzerland)|April 3, 2021
Clinical Amyloid Typing by Proteomics: Performance Evaluation and Data Sharing Between Two CentresDiana Canetti, Francesca Brambilla, Nigel B Rendell, et al.
Pageof 59